RNA Sıralama Deneyi Gen İfade ve Genomik değişiklikleri tanımlamak için hedeflenen
Summary
We describe a targeted RNA sequencing-based method that includes preparation of indexed cDNA libraries, hybridization and capture with custom probes and data analysis to interrogate selected transcripts for gene expression, mutations, and gene fusions. Targeted RNAseq permits cost-effective, rapid evaluation of selected transcripts on a desktop sequencer.
Abstract
RNA dizi (RNAseq) gen ekspresyonunu, mutasyon, gen füzyonlarının ve kodlayıcı olmayan RNA'lar algılamak ve karakterize etmek için kullanılabilir çok yönlü bir yöntemdir. 100,000,000 dizi okuma ve mRNA ve kodlayıcı olmayan RNA'lar gibi birden fazla RNA ürünlerini içerebilir – Standart RNAseq 30 gerektirir. Biz hedefli RNAseq (yakalama) bir masaüstü sequencer kullanarak seçilen RNA ürünlerde odaklanmış bir çalışma izin nasıl gösterilmektedir. RNAseq yakalama aksi geleneksel RNAseq yöntemleri kullanılarak atlanabilir, Açıklama içermeyen düşük, ya da geçici olarak ifade transkript karakterize edilebilir. Burada hücre hatları, ribozomal RNA tükenmesi, cDNA sentezi, barkodlu kütüphane, bir masaüstü sequencer üzerinde melezleme ve hedeflenen transkript yakalanması ve multipleks sıralama hazırlanması RNA çıkarma açıklar. Biz de kalite kontrol değerlendirme, hizalama, füzyon algılama, gen ifadesi miktarının ve tek MBK tanımlanmasını içeren hesaplama analiz boru hattı, anahatleotide varyantları. Bu deney, gen ekspresyonunu, gen füzyonlarının ve mutasyonları tanımlamak için hedeflenmiş transkript dizilemesi için izin verir.
Introduction
Whole transcriptome or RNA sequencing (RNAseq) is an unbiased sequencing method to assess all RNA products. The goal of targeted RNAseq (Capture) is a focused evaluation of selected transcripts with increased sensitivity, dynamic range, reduced cost or scale, and increased throughput compared to standard RNAseq. Similar to standard RNAseq, targeted enrichment approaches can be used to evaluate gene expression, multiple RNA species such as mRNA, microRNA (miRNA), lncRNA1, other noncoding RNAs2, gene fusions3, and mutations4-6.
Capture involves hybridization of complementary oligonucleotides to enrich cDNA libraries for sequencing. The rationale for RNAseq Capture is similar to microarray approaches where complementary oligonucleotides or probes are hybridized to samples and then measured for relative abundance. For microarray technologies, expression is based on relative signal measured for transcripts binding to these probes. Microarrays are thus limited by range, potential background noise from non-specific binding, and cross-hybridization of probes. Furthermore, arrays have limited dynamic range for low and highly expressed transcripts compared to RNAseq1. Microarrays are widely utilized due to their reduced cost and high throughput capacity compared to RNAseq.
Here, we demonstrate a method for RNAseq Capture that offers a middle ground between RNAseq and microarray approaches for evaluating the transcriptome. RNAseq Capture has intermediate throughput, greater dynamic range and sensitivity, and is scaled for fast turnaround on desktop sequencers. RNAseq Capture also requires reduced computational resources in terms of storage space and data processing.
Protocol
Representative Results
Discussion
RNAseq Yakalama RNAseq ve mikroarray arasında bir ara stratejisi transcriptome bir bölümüne değerlendirmek için yaklaşımlarının. Yakalama avantajları genomik değişikliklerin bir masaüstü sequencer, yüksek verimlilik ve algılama maliyeti, hızlı gerçekleştirme süresi azaltılmış sayılabilir. Yöntem olup, kodlayıcı olmayan RNA'lar 23 karakterize tek bir nükleotidi tespit etmek için adapte edilebilir RNA bağlama incelemek ve genin füzyon ya da yapısal yeniden 24 tan…
Declarações
The authors have nothing to disclose.
Acknowledgements
We give special thanks to Ezra Lyon, Eliot Zhu, Michele Wing, Esko Kautto and Eric Samorodnitsky for technical support. We would also like to thank Jenny Badillo for her administrative support for our team. We acknowledge the Ohio Supercomputer Center (OSC) for providing disk space, processing capacity, and support to run our analyses. We thank the Comprehensive Cancer Center (CCC) at The Ohio State University Wexner Medical Center for their administrative support of this work. S.R. and Team are supported by the American Cancer Society (MRSG-12-194-01-TBG), a Prostate Cancer Foundation Young Investigator Award, NHGRI (UM1HG006508-01A1), Fore Cancer Research Foundation, American Lung Association, and Pelotonia.
Materials
| Thermomixer R | Eppendorf | 21516-166 | |
| Centrifuge 5417R | Eppendorf | 5417R | |
| miRNeasy Mini Kit | Qiagen | 217004 | |
| Molecular Biology Grade Ethanol | Sigma Aldrich | E7023-6X500ML | |
| Thermoblock 24 X 1.5ml | Eppendorf | 21516-166 | |
| MiSeq Reagent Kit v2 (300-cycles) | Illumina | MS-102-2002 | |
| MiSeq Desktop Sequencer | Illumina | ||
| PhiX Control v3 | Illumina | FC-110-3001 | |
| TruSeq Stranded Total RNA Kit with RiboZero Gold SetA | Illumina | RS-122-2301 | |
| 25 rxn xGen® Universal Blocking Oligo – TS-p5 | IDT | 127040822 | |
| 25 rxn xGen® Universal Blocking Oligo – TS-p7(6nt) | IDT | 127040823 | |
| 25 rxn xGen® Universal Blocking Oligo – TS-p7(8nt) | IDT | 127040824 | |
| Agencourt® AMPure® XP – PCR Purification beads | Beckman-Coulter | A63880 | |
| Dynabeads® M-270 Streptavidin | Life Technologies | 65305 | |
| COT Human DNA, Fluorometric Grade, 1mg | Roche Applied Science | 05480647001 | |
| Qubit® Assay Tubes | Life Technologies | Q32856 | |
| Qubit® dsDNA HS Assay Kit | Life Technologies | Q32851 | |
| SeqCap® EZ Hybridization and Wash Kits (24 or 96 reactions) | Roche NimbleGen | 05634261001 or 05634253001 | |
| Qubit® 2.0 Fluorometer | Life Technologies | Q32866 | |
| 10 x 2 ml IDTE pH 8.0 (1X TE Solution) | IDT | ||
| Tween20 BioXtra | Sigma | P7949-500ML | |
| Nuclease Free Water | Life Technologies | AM9937 | |
| C1000 Touch™ Thermal Cycler with 96–Well Fast Rection Module | Biorad | 185-1196 | |
| SeqCap EZ Hybridization and Wash Kits | Roche Applied Science | 05634253001 | |
| SuperScript II Reverse Transcription 200U/ul | Life Technologies | 18064-014 | |
| D1000 ScreenTape | Agilent Technol. Inc. | 5067-5582 | |
| Agencourt RNAClean XP -40ml | Beckman Coulter Inc | A63987 | |
| RNA ScreenTape | Agilent Technol. Inc. | 5067-5576 | |
| RNA ScreenTape Ladder | Agilent Technol. Inc. | 5067-5578 | |
| RNA ScreenTape Sample Buffer | Agilent Technol. Inc. | 5067-5577 | |
| Sodium Hydroxide | Sigma | 72068-100ML | |
| DynaBeads MyOne Streptavidin T1 | Life Technologies | 65602 | |
| DYNAMAG -96 SIDE EACH | Life Technologies | 12331D | |
| Chloroform | Sigma | C2432-1L | |
| KAPA HotStart ReadyMix | KAPA Biosystems | KK2602 | |
| NanoDrop 2000 Spectrophotometer | Thermo Scientific | ||
| My Block Mini Dry Bath | Benchmark | BSH200 | |
| D1000 Reagents | Agilent Technol. Inc. | 5067- 5583 | |
| Vacufuge Plus | Eppendorf | 022829861 |
Referências
- Wang, Z., Gerstein, M., Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 10, 57-63 (2009).
- Mercer, T. R., et al. Targeted sequencing for gene discovery and quantification using RNA CaptureSeq. Nat Protoc. 9, 989-1009 (2014).
- Maher, C. A., et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci U S A. 106, 12353-12358 (2009).
- Piskol, R., Ramaswami, G., Li, J. B. Reliable identification of genomic variants from RNA-seq data. Am J Hum Genet. 93, 641-651 (2013).
- Quinn, E. M., et al. Development of strategies for SNP detection in RNA-seq data: application to lymphoblastoid cell lines and evaluation using 1000 Genomes data. PLoS One. 8, e58815 (2013).
- Tang, X., et al. The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data. Nucleic Acids Res. 42, e172 (2014).
- . Preparing Libraries for Sequencing on the MiSeq® Available from: https://support.illumina.com/content/dam/illumina-support/documents/documentation/system_documentation/miseq/preparing-libraries-for-sequencing-on-miseq-15039740-d.pdf (2013)
- . MiSeq® Reagent Kit v2 Reagen Preparation Guide Available from: https://support.illumina.com/downloads/miseq_reagent_kit_reagent_preparation_guide.html (2012)
- Kim, D., et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
- Li, H., et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 25, 2078-2079 (2009).
- DeLuca, D. S., et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics. 28, 1530-1532 (2012).
- Dobin, A., et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 29, 15-21 (2013).
- Van der Auwera, G. A., et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 11, 11.10.1-11.10.33 (2013).
- Trapnell, C., et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 28, 511-515 (2010).
- Iyer, M. K., Chinnaiyan, A. M., Maher, C. A. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics. 27, 2903-2904 (2011).
- Kim, D., Salzberg, S. L. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol. 12, R72 (2011).
- Fernandez-Cuesta, L., et al. Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data. Genome Biol. 16, 7 (2015).
- Shugay, M., Ortiz de Mendibil, ., Vizmanos, I., L, J., Novo, F. J. Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions. Bioinformatics. 29, 2539-2546 (2013).
- Clark, M. B., et al. Quantitative gene profiling of long noncoding RNAs with targeted RNA sequencing. Nat Methods. 12, 339-342 (2015).
- Cieslik, M., et al. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing. Genome Res. , (2015).
- Cabanski, C. R., et al. cDNA hybrid capture improves transcriptome analysis on low-input and archived samples. J Mol Diagn. 16, 440-451 (2014).
- Costa, C., Gimenez-Capitan, A., Karachaliou, N., Rosell, R. Comprehensive molecular screening: from the RT-PCR to the RNA-seq. Transl Lung Cancer Res. 2, 87-91 (2013).
- Zhao, W., et al. Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling. BMC Genomics. 15, 419 (2014).
